Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?

Title
Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?
Authors
Keywords
Endometrial Cancer, POLE-ultramutated, MSI-hypermutated, PD-1/PD-L1 axis, Immunotherapy, Tumor Infiltrating Lymphocytes (TILs)
Journal
CANCER TREATMENT REVIEWS
Volume 48, Issue -, Pages 61-68
Publisher
Elsevier BV
Online
2016-06-27
DOI
10.1016/j.ctrv.2016.06.008

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started